Mind Medicine Inc (NASDAQ: MNMD) kicked off on Friday, down -4.77% from the previous trading day, before settling in for the closing price of $7.54. Over the past 52 weeks, MNMD has traded in a range of $3.49-$12.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 40.57%. With a float of $27.23 million, this company’s outstanding shares have now reached $81.59 million.
Let’s look at the performance matrix of the company that is accounted for 57 employees. In terms of profitability, gross margin is 72.78%, operating margin of -1935.9%, and the pretax margin is -2021.54%.
Mind Medicine Inc (MNMD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Dec 26 ’24, was worth 141,958. In this transaction Chief Executive Officer of this company sold 19,106 shares at a rate of $7.43, taking the stock ownership to the 526,666 shares. Before that another transaction happened on Dec 26 ’24, when Company’s Chief Accounting Officer sold 2,273 for $7.43, making the entire transaction worth $16,888. This insider now owns 97,270 shares in total.
Mind Medicine Inc (MNMD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 40.57% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Take a look at Mind Medicine Inc’s (MNMD) current performance indicators. Last quarter, stock had a quick ratio of 9.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.09, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Mind Medicine Inc (NASDAQ: MNMD) saw its 5-day average volume 1.4 million, a negative change from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 54.34%. Additionally, its Average True Range was 0.61.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 44.57%, which indicates a significant decrease from 45.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.03% in the past 14 days, which was higher than the 70.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.25, while its 200-day Moving Average is $7.60. Nevertheless, the first resistance level for the watch stands at $7.68 in the near term. At $8.19, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.49. If the price goes on to break the first support level at $6.87, it is likely to go to the next support level at $6.57. Assuming the price breaks the second support level, the third support level stands at $6.06.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
The company with the Market Capitalisation of 501.38 million has total of 73,332K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -95,730 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -13,680 K.
